NCT04999397 is a clinical trial of standards clinical management in Penetrating Cardiac Trauma, sponsored by University of Witwatersrand, South Africa.

Who is sponsoring NCT04999397?

NCT04999397 is sponsored by University of Witwatersrand, South Africa.

What drugs are being tested in NCT04999397?

Interventions in NCT04999397: standards clinical management.

What condition does NCT04999397 study?

NCT04999397 studies Penetrating Cardiac Trauma.

Is NCT04999397 still recruiting?

NCT04999397 is currently completed. Last updated 25 August 2021.

Last reviewed 2021-08-25 · How we verify

NCT04999397

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Penetrating Cardiac Injuries: Outcome of Treatment From a Level 1 Trauma Centre in South

Completed Last updated 25 August 2021

What this trial tests

trial testing standards clinical management in Penetrating Cardiac Trauma in 167 participants. Completed in 31 December 2019.

Timeline

1 January 2016

Primary endpoint
31 December 2019

31 December 2019

Quick facts

Lead sponsor	University of Witwatersrand, South Africa
Status	Completed
Study type	OBSERVATIONAL
Enrollment	167
Start date	1 January 2016
Primary completion	31 December 2019
Estimated completion	31 December 2019
Sites	1 location across South Africa

Drugs / interventions tested

standards clinical management

Conditions studied

Penetrating Cardiac Trauma — all drugs for Penetrating Cardiac Trauma →

Sponsor

University of Witwatersrand, South Africa

Who can join

18 and older, any sex, with Penetrating Cardiac Trauma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Retrospective observational study design auditing the outcomes of cardiac injuries in a single centre

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other University of Witwatersrand, South Africa trials

Trials by the same sponsor.

NCT06821152 — Functional Performance and Acceptability Evaluation of the Miss Liberty Female Condom Compared to the FC2 Female Condom · NA · completed
NCT06955728 — A Clinical Trial on Safety in Pregnant Women and How Well the Infant is Protected Against RSV-associated Lower Respirato · Phase 4 · not yet recruiting
NCT06485154 — Post-Injectable Cabotegravir Antiretroviral Salvage Strategy Options Trial · Phase 4 · active not recruiting
NCT06138600 — Acceptability and Feasibility of Injectable Cabotegravir Pre-exposure Prophylaxis (PrEP) Versus Oral PrEP in Routine Car · Phase 3 · active not recruiting
NCT05846503 — iHEART-SA Intervention Study · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04999397 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Witwatersrand, South Africa
Last refreshed: 25 August 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04999397.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing